The oligonucleotide synthesis market is anticipated to grow at a CAGR of around 12.7% during the forecast period. The growth in the life science industries and rising application in therapeutics, genetics, and genomics in the research and diagnostics.The oligonucleotide synthesis market has been growing significantly owing to increasing online and strong pipelines of the oligonucleotide, the growing burden of chronic diseases and rising consolidation of the market. However, lack of regulatory scenario for the oligonucleotide, challenging drug delivery technique and complex therapeutics classification owing to a large range of oligonucleotides is the restraining factor that hampers the market growth.

Request a Free Sample of our Global Oligonucleotide Synthesis Market: https://www.omrglobal.com/request-sample/oligonucleotide-synthesis-market

The oligonucleotides services offered by the manufacturers are available based on the customer requirement that enables the identification of specific genes in the procedure of life science research. Different types of fragment oligonucleotides are available that are prepared and used by various industry such as for research for life science, the oligos are utilized as PCR probes and primers, gene editing (CRISPR), and DNA sequencing for the diagnostics applications. Currently, the market has witnessed a considerable increase in the acquisition of various small-scale oligonucleotide synthetic companies by key players to vast their product & services offerings and improve their presence in the market. For instance, in April 2019, GenScript had announced a launch of single-stranded DNA services. The new services provide researchers to access high quality, DNA for CRISPER based gene insertion, cell therapy, enabling to accelerate the development of gene therapy and also the transgenic animal model for cancer treatment. Moreover, across the globe,the oligonucleotide synthesis market is increasing owing to favorable government policies, increasing prevalence of infectious diseases such as hepatitis and cancer, advancements in synthesis technology, and ongoing research in synthetic biology. Moreover, the large range of applications in the area of research, therapeutics, data storage, synthetic biology, increasing research-oriented programs, diagnostics, and drug discovery are fuelling the requirement of the oligonucleotide synthesis in the biotechnology industry.

A full Report of Global Oligonucleotide Synthesis Market is Available at: https://www.omrglobal.com/industry-reports/oligonucleotide-synthesis-market

Currently, the market has witnessed a considerable increase in the acquisition of various small-scale oligonucleotide synthetic companies by key players to vast their product & services offerings and improve their presence in the market. For instance, in April 2019, GenScript had announced a launch of single-stranded DNA services. The new services provide researchers to access high quality, DNA for CRISPER based gene insertion, cell therapy, enabling to accelerate the development of gene therapy and also the transgenic animal model for cancer treatment. Moreover, across the globe,the oligonucleotide synthesis market is increasing owing to favorable government policies, increasing prevalence of infectious diseases such as hepatitis and cancer, advancements in synthesis technology, and ongoing research in synthetic biology.

Global Oligonucleotide Synthesis Market Segmentation

By Product

• Synthesized Oligonucleotide Product
• Probe
• Primer
• Other (Linkers)
• Reagent
• Equipment

By Type

• Custom
• Pre-Designed
By Application
• Research
• Diagnostics
• Therapeutics

Regional Analysis

• North America
• US
• Canada
• Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Rest of the World

Company Profiles

• Agilent Technologies, Inc.
• Ajinomoto Co., Inc.
• ATDBio, Ltd.
• Biolytic Lab Performance Inc.
• Bio-Synthesis Inc.
• Danaher Corp.
• Eurofins Genomics, LLC
• Eurogentec S.A.
• General Electric (GE) CO.
• GenScriptBiotech Corp.
• LGC, Ltd.
• Merck KGaA
• Nitto Denko Avecia Inc.
• PolygenGmbh
• Quintara Biosciences
• Thermo Fisher Scientific, Inc.
• Twist Bioscience Corp.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/oligonucleotide-synthesis-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404